Qinghaosu (Artemisinin): The Price of Success
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Artemisinin and its derivatives have become essential components of antimalarial treatment. These plant-derived peroxides are unique among antimalarial drugs in killing the young intraerythrocytic malaria parasites, thereby preventing their development to more pathological mature stages. This results in rapid clinical and parasitological responses to treatment and life-saving benefit in severe malaria. Artemisinin combination treatments (ACTs) are now first-line drugs for uncomplicated falciparum malaria, but access to ACTs is still limited in most malaria-endemic countries. Improved agricultural practices, selection of high-yielding hybrids, microbial production, and the development of synthetic peroxides will lower prices. A global subsidy would make these drugs more affordable and available. ACTs are central to current malaria elimination initiatives, but there are concerns that tolerance to artemisinins may be emerging in Cambodia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“iron-catalysed radical formation is also significantly involved in the antimalarial (i.e. cytotoxic) mode of action of artemisinin [1494,1496-1504], and this reaction is in fact inhibited by iron chelators [1505] such that a combined artemisinin-chelator therapy would be contraindicated.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1504]
Citations
Cites
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Bhattarai, A., Ali, A. S., Kachur, S. P., Mårtensson, A., Abbas, A. K., Khatib, R., Al-mafazy, A.-W., Ramsan, M., Rotllant, G., Gerstenmaier, J. F., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040309 · Cited by 647
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575
Self-citationWhite, N., Nosten, F., Looareesuwan, S., Watkins, W., Marsh, K., Snow, R., Kokwaro, G., Ouma, J., Hien, T., Molyneux, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07367-x · Cited by 543
Self-citationArtesunate combinations for treatment of malaria: meta-analysis
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15162-8 · Cited by 538
Self-citationThiers, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70110-2 · Cited by 512
Research works printed but not linked: 11
- Qinghaosu Antimalarial Coordinating Research Group, Chin. Med. J. (Engl.)92, 811 (1979).
- J. B. Jianget al., Lancet2, 285 (1982).
- G. Q. Liet al., J. Tradit. Chin. Med.2, 125 (1982).
- W. Peters, Pharmacol. Ther.47, 499 (1990).
- F. ter Kuileet al., Exp. Parasitol.76, 86 (1993).
- P. Q. Chenet al., Chin. Med. J. (Engl.)107, 709 (1994).
- R. Jambouet al., Lancet366, 1960 (2005). · doi:10.1016/s0140-6736(05)67787-2
- I. Nakase, H. Lai, N. P. Singh, T. Sasaki, Int. J. Pharm.354, 28 (2007).
- International Artemisinin Study Group, Lancet363, 9 (2004). · DOI · Paper page
- M. van Vugt, Am. J. Trop. Med. Hyg.62, 65 (2000).
- Wkly. Epidemiol. Rec.82, 360 (2007).
Cited by
Items 801–900 of 961
Phenotypic and Genotypic Analysis of In Vitro Selected Artemisinin Resistant Plasmodium falciparum
Tucker, M. S. (2010) · Digital Commons - University of South Florida (University of South Florida) · Cited by 4
The role of molecular markers in emerging artemether-lumefantrine resistant Plasmodium falciparum
Malmberg, M. (2012) · Figshare · Cited by 2
N‐Myristoyltransferase as a Target for Drug Discovery in Malaria
Brannigan, J. A., & Wilkinson, A. J. (2016) · doi:10.1002/9783527694082.ch12 · Cited by 1
Characterization of artemisinin resistance in plasmodium falciparum
Rocamora, F. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72647 · Cited by 1
Hattingh, S. M. (2018) · Boloka Institutional Repository (North-west University) · Cited by 1
Preventive effect of Artemisia annua extract on schistosomiasisPreprint
man, Y., Xu, Y., Sun, J., Guo, Y., Jia, P., Mi, R., Yan, H., & 朱传刚 (2022) · Research Square · doi:10.21203/rs.3.rs-1579569/v1 · Cited by 1
Various antimalarial strategies in Indonesia to fight Plasmodium falciparum
Ramadani, A. P. (2017) · theses.fr (ABES) · doi:10.70675/457feb93z0ec0z406cz9ff9zb56a726b134f · Cited by 3
Bell, D. J., & Lalloo, D. G. (2013) · Wiley eBooks · doi:10.1002/9781118392058.ch10
Natural products AKTing on signal transduction pathways-molecules and methods
Kiefer, S. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005151603 · Cited by 1
“However, due to the short plasma half-life of these drugs therapy needs to be continued for 5-7 days, or needs to be combined with other antimalarial drugs (White, 2008).”
BackgroundAsimus, S. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
A novel antimalarial lead compound: in vitro properties and mode of action studies
Brunner, R. (2011) · edoc (University of Basel) · doi:10.5451/unibas-005657443
“Chemically, artemisinins belong to the class of sesquiterpene lactones and have an endoperoxide bridge which is essential for antimalarial activity (reviewed by White 2008).”
BackgroundRöshammar, D. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a
Witkowski, B., Lelièvre, J., Barragán, M. J. L., Laurent, V., Su, X., Berry, A., & Benoit‐Vical, F. (2010)
del Villar-Moro, L. P. (2012) · Gredos (University of Salamanca) · doi:10.14201/gredos.121401
Molecular analysis of membrane transporters implicated in drug resistance.
Lekostaj, J. K. (2011) · DigitalGeorgetown (Georgetown University Library)
Role of the pfmdr1 Gene in Plasmodium falciparum Resistance to Antimalarial Treatment
Bohórquez, E. (2012) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xcxr-8m10
Polymorphism of Pfatpase6 in Cte dIvoire: Detection of a four new point mutations
Brice, K. B., Jonhson, N. D. T., Houphouet, F. Y., Yavo, W., Francis, A. Y., & Joseph, A. D. (2015) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2014.13942
“ARTs contain an endoperoxide bridge that is essential for the parasitekilling activities (White, 2008).”
BackgroundFirman, J. W. (2015) · University of Liverpool · doi:10.17638/02012740
Monoelectronic reduction of dihydroartemsisinin (DHA): pH dependence and product analysis
Navacchia, M. L., Capobianco, M. L., D’Angelantonio, M., & Marconi, G. (2013) · Tetrahedron Letters · doi:10.1016/j.tetlet.2013.07.088
Mapping the Origins and Spread of Antifolate-Resistant Malaria Parasites
Hyde, J. E. (2009) · Future Microbiology · doi:10.2217/fmb.09.66
[Intra-pituitary dermoid cyst].
Gabbrielli, S., & Telleschi, S. (1971) · PubMed
Evidence-based Anticancer Materia Medica for Leukemia
Li‐Weber, M. (2011) · Evidence-based anticancer complementary and alternative medicine · doi:10.1007/978-94-007-1983-5_12 · Cited by 1
Analysis of Plasmodium falciparum Chloroquine Resistance Transporters in Saccharomyces cerevisiae
Baro, N. K. (2012) · DigitalGeorgetown (Georgetown University Library)
Computational Investigation into Catalytic Mechanisms of Disease-Causing Enzymes and Biocatalysts
MacDonald, C. A. (2015) · DalSpace (Dalhousie University)
Innere, A., Vii, M., Direktor, Ä., & Kremsner, P. G. (2010)
Singh, H. (2012) · doi:10.21007/etd.cghs.2012.0292
“From the pool of validated hits demonstrating positive correlation with cellular c-MYC expression for their drug activity, we selected the artemisinin class of FDA-approved and very well-tolerated antimalarial drugs (ARTs) which included artemisinin, artesunate, and dihydroartemisinin (DHA) [104].”
BackgroundPoorebrahi, M., Hoseinzade, A. H., Omidi, M., Asghari, M., & Sanadgol, N. (2013) · American Journal of Biochemistry and Molecular Biology · doi:10.3923/ajbmb.2013.379.387
Zone, J., Abdo, N., Bedru, K. H., Fekadu, S., Wieser, A., Pritsch, M., Löscher, T., & Berens‐Riha, N. (2012)
Phenotypic and Genotypic Analysis of In Vitro Selected Artemisinin Resistant
Tucker, M. S., & Falciparum, P. (2010)
Host Factor Pharmacogenetics for Treatment of Infectious Diseases
Slev, P. R., & Hillyard, D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_20
South Sudan to Martha's Vineyard: Malaria Always First!
Antinori, S., Milazzo, L., Sollima, S., & Corbellino, M. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.10.044
Antimalarial Compound Synthesis from Transgenic Cultures
Kundu, S., Mukherjee, S., & Ghosh, B. (2017) · Reference series in phytochemistry · doi:10.1007/978-3-319-28669-3_22 · Cited by 1
Lemieux, P. B., Pribilsky, J., & Majors, I. P. (2014)
Metabolic engineering and synthetic biology of plant secondary metabolism
Nielsen, L., Bjarnholt, N., Blomstedt, C. K., Gleadow, R. M., & Møller, B. L. (2016) · CRC Press eBooks · doi:10.1201/9781315370453-14
Nuclear Peroxiredoxine: A promising Target for Drug & Diagnostic Solutions of Malaria
Kumar, N. (2016) · Journal of Bacteriology & Mycology Open Access · doi:10.15406/jbmoa.2016.03.00056
Optimization driven approaches for subsidy allocation and supply chain procurement
Romero, G. (2014) · DSpace@MIT (Massachusetts Institute of Technology)
Wicaksono, I. A., Lestari, T., Ulfa, E. U., Riani, C., & Elfahmi, E. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10s2.19491
Uche, F. I. (2017) · Keele Research Repository (Keele University)
Ye, X.-Y., Ling, Q., & Shao-jun, C. (2017) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000216087
“Artemisinin and its derivatives are unique among antimalarial drugs because they kill the young intraerythrocytic malaria parasite, thereby preventing its advancement into a more pathological mature stage (White, 2008).”
BackgroundPhysiology Directed Drug Discovery in Multidrug Resistant Plasmodium falciparum
Siriwardana, A. (2017) · DigitalGeorgetown (Georgetown University Library)
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants
Njokah, J., Kinyua, J. D. M., Kariuki, D. W., & Kimani, F. T. (2016)
PHARMACOLOGY AND PHARMACODYNAMICS OF SELECTED ANTIMALARIALS AGAINST P. falciparum GAMETOCYTES
Saif, A. (2017) · University of Liverpool · doi:10.17638/03005700
Natural Product Synthesis for Drug Discovery and Chemical Biology
Yao, Z., & Wei, W. (2018) · Wiley eBooks · doi:10.1002/9781118940228.ch10
Artemisinin: A Potent Antimalarial Drug
Malaviya, A., Malhotra, K., Agarwal, A., & Saikia, K. (2019) · Wiley eBooks · doi:10.1002/9781119460053.ch15
Synthetic Biology: A Novel Approach for Pharmaceutically Important Compounds
Rashmi, Kumar, U., Maan, P., & Priyanka (2019) · Fungal biology · doi:10.1007/978-3-030-14846-1_16
Woessner, M. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j8vt-t341
Metabolic engineering and synthetic biology of plant secondary metabolism
Ro, D., Qu, Y., & Kwon, M. (2016) · doi:10.1201/9781315370453-20
Ali, S., Jafery, N., Farhat, K., & Waheed, A. (2017) · PubMed
Structure-based drug discovery aiming at human-diseases related protein targets
Gao, K. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.133808191
Natural Product Inspired Synthesis of Tryptanthrin Analogues as Potential Antimalarial Agents
Tripathi, V. D. (2020) · Asian Journal of Organic & Medicinal Chemistry · doi:10.14233/ajomc.2020.ajomc-p302
Qiao, Z., Du, H., & Li, X. (2021) · Archives of Medical Science · doi:10.5114/aoms/118378 · Cited by 1
“Artemisinin (ART), which was first extracted from Artemisia annua by Tu Youyou, has been used as an efficient drug for curing malaria [7].”
BackgroundMaoJing, Z.-G., Wang, Z., HeWei-wei, D.-S., Liao, X.-Z., QiuYong-hong, L.-B., & Wang, Z.-J. (2012)
Metabolic engineering of artemisinin biosynthesis in Artemisia annua L.
LiuHong, B., Du, W., & Ye, G. L. (2011)
Six-Membered Rings With 1,2,4-Oxygen or Sulfur Atoms
Rawat, D. S., & Verma, G. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818655-8.00095-0
Sherman, I. W. (2014) · ASM Press eBooks · doi:10.1128/9781555816889.refs
Reisinger, C. M. (2012) · Springer theses · doi:10.1007/978-3-642-28118-1_2
Kumari, J., Kumar, V., Behl, A., Sah, R. K., Garg, S., Pati, S., Samby, K., Burrows, J. N., Mohandas, N., & Singh, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.28.489976
“Artemisinin, an extremely potent and fast-acting anti-malarial drug was 44 proposed to have indispensable role in malaria therapies when used in combination with other 45 anti-malarials such as mefloquine or lumenfantine [1].”
Background38.11 Acyclic Geminal Bisperoxides
Андреевна, В. В., Bityukov, O. V., & Terent'ev, A. O. (2019) · Haug Verlag in Georg Thieme Verlag KG eBooks · doi:10.1055/sos-sd-138-00067
Molecular Pathogenesis of Malaria
Roberts, D. J., & Chitnis, C. E. (2010) · doi:10.1002/9781444318531.ch16
Antimalarial Compound Synthesis from Transgenic Cultures
Kundu, S., Mukherjee, S., & Ghosh, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-27490-4_22-1
Yeshanew, S., Gete, W., & Chilo, D. (2021) · Research Square · doi:10.21203/rs.3.rs-183304/v1
Loup, G. L., & Malvy, D. J.-M. (2010) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(09)22583-x
Interventions and Practical Approaches to Reduce the Burden of Malaria on School-Aged Children
Macnab, A. J. (2022) · Infectious diseases · doi:10.5772/intechopen.106469 · Cited by 2
Lim, P. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Artemisinin drug resistance and monitoring: a narrative review
Iwuafor, A. A., Ogban, G., Emanghe, U. E., Erengwa, P. C., Offiong, A. B., Nsor, G. E., & Owai, P. A. (2023) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v24i2.1 · Cited by 2
“rial activity such as rapid onset of action, short half-life and activity against different stages in the life cycle of the malaria parasite (18).”
BackgroundConservation of red blood cell signalling in Plasmodium merozoite invasion
Yong, J. J. M. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/169702
AN UNUSUAL MALARIA CASE: MIXED INFECTION? RESISTANCE? MALADAPTIVE PATIENT?
Şahin, A. M., ÖZTÜRK, H., Çetin, S., Aydın, E., Şenel, İ., & Yetkin, M. A. (2023) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1229345
CYP screening for a better terpenoid world
Han, J.-N., & Li, S. (2023) · Nature Catalysis · doi:10.1038/s41929-023-01064-6
Xenobiotics in Traditional Medicine Practices and Quality Control Strategies
Yarkwan, B., & Isaac, O. T. (2023) · Reference series in phytochemistry · doi:10.1007/978-3-031-21973-3_30-1
Examples for successful commercial production of plant-derived bioactive compounds
Qu, L., Deng, J., & Fan, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15584-0.00003-3
Mishra, J. (2024) · PLANT ARCHIVES · doi:10.51470/plantarchives.2024.v24.no.1.133
“In addition, some other important molecules like papaverine was the basis for development of buguanidine type drug development, quinine for malaria and other potent drugs from plant sources (White, 2008).”
BackgroundGeneration of liver tissue-resident memory T cells with novel NKT cell agonists and mRNA vaccines
Ganley, M. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25792368
Xenobiotics in Traditional Medicine Practices and Quality Control Strategies
Yarkwan, B., & Isaac, O. T. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-43199-9_30
Saha, T., & Hoque, M. E. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-4600-2_2
The hybrid antimalarial approach: A roadmap: 2024
Singh, L., & Singh, K. (2024) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2024.09.006
Catalyst-free coupling of peroxypyrroloindolenines with amines to afford stable peroxyindolenines
Zheng, X., Wang, M., Sun, X., Gao, Y., & Chen, H. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob01736f
Frimpong, D. A., Moomin, A., Asare–Nkansah, S., Antwi, A. O., Sidik, A. I., Adu-Gyamfi, P. K. T., & Mensah, K. B. (2025) · Scientific African · doi:10.1016/j.sciaf.2025.e02569
Patil, M. R. C. (2025) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2025.69349
Wu, B. (2025) · The Natural Products Journal · doi:10.2174/0122103155385884250505072518
Prenen, F., Pauw, B. D., Knoops, S., Pollenus, E., Possemiers, H., Weyenbergh, J. V., & den Steen, P. E. V. (2025) · Malaria Journal · doi:10.1186/s12936-025-05462-y · Cited by 1
Duensing, H. M., Dixon, J. M., Hunter, O. R., Graves, N. C., Smith, N. C., Tomes, A. J., & Fahrenholtz, C. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146628 · Cited by 2
“To date, preclinical efficacy has not been determined for MPNSTs. Artemisinins have a well-established safety profile in the clinic for malaria [25] and have been shown to be safe as part of cancer treatment regimens [26]; therefore, we evaluated the preclinical efficacy of artemisinins as…”
Selected Terpenes and More: “Again Dope or Medicine?”
Steinberg, C. E. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-97988-0_5
Effects of artesunate-loaded nanoparticles on Plasmodium berghei treatment in a mouse model
Wen, H., Li, Y., Luo, J., Zhu, W., Hide, G., Feng, X., Lun, Z., & Lai, D. (2025) · Acta Tropica · doi:10.1016/j.actatropica.2025.107823
Microbial Production of Terpenes
Pimentel, L. L., Çarşanba, E., Teixeira, F. S., Vidigal, S. S. M. P., Pintado, M., Oliveira, C., & Rodríguez-Alcalá, L. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-90974-0_2
A review of Potentilla discolor Bunge: ethnomedicinal uses, phytochemistry, and pharmacology
Shen, T., Xie, J.-C., He, Y., & Yang, H. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00864-4
“Artemisinin is an antimalarial drug extracted from Artemisia annua (White 2008), and paclitaxel is an anticancer drug derived from Taxus brevifolia (Wani et al. 1971).”
Sun, Y., Cui, Y., Huang, Y., & Xu, M. (2025) · Global Health Research and Policy · doi:10.1186/s41256-025-00454-6
Colizzi, F. (2009) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/1862
Tempera, C. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tam, D. N. H., Tawfik, G. M., El‐Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S., Tu, V. L., Tiwari, R., Van Dat, T., Nguyen, P. T. V., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12845621
Tam, D. N. H., Tawfik, G. M., El‐Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S., Tu, V. L., Tiwari, R., Van Dat, T., Nguyen, P. T. V., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12845663
Tam, D. N. H., Tawfik, G. M., El‐Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S., Tu, V. L., Tiwari, R., Van Dat, T., Nguyen, P. T. V., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12845639
Tam, D. N. H., Tawfik, G. M., El‐Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S., Tu, V. L., Tiwari, R., Van Dat, T., Nguyen, P. T. V., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12845618
Tam, D. N. H., Tawfik, G. M., El‐Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S., Tu, V. L., Tiwari, R., Van Dat, T., Nguyen, P. T. V., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12845675
Tam, D. N. H., Tawfik, G. M., El‐Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S., Tu, V. L., Tiwari, R., Van Dat, T., Nguyen, P. T. V., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12845678
Metadata
- Authors
- White, N. J.
- Affiliations
- Mahidol University (TH)
- Corresponding author
- White, N. J.
- ORCID
- White, N. J.
- Venue
- Science
- Published
- 2008-04-18
- Volume
- 320
- Issue
- 5874
- Pages
- 330-334
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2076029682
- Cited by
- 954
- References
- 53
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 42 · 2023: 32 · 2022: 32 · 2021: 39 · 2020: 86 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 61 · 2015: 57 · 2014: 41 · 2013: 54 · 2012: 72
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- artemisinin, Artemisia annua, artemisinin-based combination therapy, antimalarial drugs, drug affordability, malaria treatment, falciparum malaria, artemisinin resistance, agricultural practices, drug pricing
- MeSH terms
- Animals, Antimalarials, Drug Resistance, Drug Therapy, Combination, Health Services Accessibility, Humans, Plasmodium falciparum, Drug Costs, Malaria, Falciparum, Cost of Illness, Artemisia, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.